Clinicopathological Features of Insertion Mutations in Kinase Domain of EGFR and ERBB2 in Non-Small-Cell Lung Cancer

被引:0
|
作者
Zhao, Ruiying [1 ]
Xiang, Chan [1 ]
Zhu, Lei [1 ]
Shao, Jinchen [1 ]
Zhao, Jikai [1 ]
Guo, Lianying [1 ]
Ma, Shengji [1 ]
Yu, Anbo [1 ]
Han, Yuchen
机构
[1] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Shanghai, Peoples R China
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
1977
引用
收藏
页码:1833 / 1834
页数:2
相关论文
共 50 条
  • [41] Epiregulin confers EGFR-TKI resistance via EGFR/ErbB2 heterodimer in non-small cell lung cancer
    Shiqi Ma
    Lu Zhang
    Yuan Ren
    Wei Dai
    Tingqing Chen
    Liping Luo
    Juan Zeng
    Kun Mi
    Jinyi Lang
    Bangrong Cao
    [J]. Oncogene, 2021, 40 : 2596 - 2609
  • [42] Epiregulin confers EGFR-TKI resistance via EGFR/ErbB2 heterodimer in non-small cell lung cancer
    Ma, Shiqi
    Zhang, Lu
    Ren, Yuan
    Dai, Wei
    Chen, Tingqing
    Luo, Liping
    Zeng, Juan
    Mi, Kun
    Lang, Jinyi
    Cao, Bangrong
    [J]. ONCOGENE, 2021, 40 (14) : 2596 - 2609
  • [43] Average gene copy number (AGCN) analysis of erbB1 and erbB2 in non-small-cell lung cancer (NSCLC)
    Konopa, K
    Zaczek, A
    Bielawski, K
    Jakóbkiewicz, J
    Zylicz, M
    Dziadziuszko, R
    Rzyman, W
    Jassem, J
    [J]. LUNG CANCER, 2004, 45 : S30 - S30
  • [44] EGFR Exon 20 Insertion Mutations: Clinicopathological Characteristics and Treatment Outcomes in Advanced Non-Small Cell Lung Cancer
    Leal, Jose Luis
    Alexander, Marliese
    Itchins, Malinda
    Wright, Gavin M.
    Kao, Steven
    Hughes, Brett G. M.
    Pavlakis, Nick
    Clarke, Stephen
    Gill, Anthony J.
    Ainsworth, Hannah
    Solomon, Benjamin
    John, Thomas
    [J]. CLINICAL LUNG CANCER, 2021, 22 (06) : E859 - E869
  • [45] Non-small-cell lung cancer (NSCLC) tumors from gefitinib-responsive patients (pts) harbor EGFR kinase domain mutations
    Rosell, Rafael
    Ichinose, Yukito
    Taron, Miquel
    Sarries, Carme
    Queralt, Cristina
    Ono, Mayumi
    Manegold, Christian
    Mok, Tony
    Miguel Sanchez, Jose
    Massuti, Bartomeu
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 166 - 166
  • [46] Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of ERBB2
    Greulich, Heidi
    Kaplan, Bethany
    Mertins, Philipp
    Chen, Tzu-Hsiu
    Tanaka, Kumiko E.
    Yun, Cai-Hong
    Zhang, Xiaohong
    Lee, Se-Hoon
    Cho, Jeonghee
    Ambrogio, Lauren
    Liao, Rachel
    Imielinski, Marcin
    Banerji, Shantanu
    Berger, Alice H.
    Lawrence, Michael S.
    Zhang, Jinghui
    Pho, Nam H.
    Walker, Sarah R.
    Winckler, Wendy
    Getz, Gad
    Frank, David
    Hahn, William C.
    Eck, Michael J.
    Mani, D. R.
    Jaffe, Jacob D.
    Carr, Steven A.
    Wong, Kwok-Kin
    Meyerson, Matthew
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (36) : 14476 - 14481
  • [47] EGFR haplotypes confer risk for tyrosine kinase domain mutations in non-small cell lung cancer
    Liu, Wanqing
    He, Lijun
    Krishnaswamy, Soundararajan
    Kanteti, Rajani
    Wang, Yi-Ching
    Salgia, Ravi
    Ratain, Mark
    [J]. CANCER RESEARCH, 2009, 69
  • [48] Targeting EGFR in non-small-cell lung cancer
    Doroshow, JH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (02): : 200 - 202
  • [49] Somatic mutations of EGFR, ERBB2, ERBB3 and ERBB4 in juxtamembrane activating domains are rare in non-small cell lung cancers
    Park, Sang Wook
    Chung, Nak Gyun
    Han, Ji Youn
    Eom, Hyeon Seok
    Yoo, Nam Jin
    Lee, Sug Hyung
    [J]. APMIS, 2010, 118 (01) : 83 - 84
  • [50] Frequency of EGFR Mutations in Greek Non-Small-Cell Lung Cancer (NSCLC) Patients
    Nasioulas, G.
    Efstathiadou, C.
    Murray, S.
    Dahabreh, I.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S635 - S635